338 related articles for article (PubMed ID: 10764590)
1. Ligand-induced stabilization of PPARgamma monitored by NMR spectroscopy: implications for nuclear receptor activation.
Johnson BA; Wilson EM; Li Y; Moller DE; Smith RG; Zhou G
J Mol Biol; 2000 Apr; 298(2):187-94. PubMed ID: 10764590
[TBL] [Abstract][Full Text] [Related]
2. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma.
Nolte RT; Wisely GB; Westin S; Cobb JE; Lambert MH; Kurokawa R; Rosenfeld MG; Willson TM; Glass CK; Milburn MV
Nature; 1998 Sep; 395(6698):137-43. PubMed ID: 9744270
[TBL] [Abstract][Full Text] [Related]
3. Subtype specific effects of peroxisome proliferator-activated receptor ligands on corepressor affinity.
Stanley TB; Leesnitzer LM; Montana VG; Galardi CM; Lambert MH; Holt JA; Xu HE; Moore LB; Blanchard SG; Stimmel JB
Biochemistry; 2003 Aug; 42(31):9278-87. PubMed ID: 12899614
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalpha.
Xu HE; Stanley TB; Montana VG; Lambert MH; Shearer BG; Cobb JE; McKee DD; Galardi CM; Plunket KD; Nolte RT; Parks DJ; Moore JT; Kliewer SA; Willson TM; Stimmel JB
Nature; 2002 Feb; 415(6873):813-7. PubMed ID: 11845213
[TBL] [Abstract][Full Text] [Related]
5. Effects of ligand binding on the association properties and conformation in solution of retinoic acid receptors RXR and RAR.
Egea PF; Rochel N; Birck C; Vachette P; Timmins PA; Moras D
J Mol Biol; 2001 Mar; 307(2):557-76. PubMed ID: 11254382
[TBL] [Abstract][Full Text] [Related]
6. Metal-dependent folding and stability of nuclear hormone receptor DNA-binding domains.
Low LY; Hernández H; Robinson CV; O'Brien R; Grossmann JG; Ladbury JE; Luisi B
J Mol Biol; 2002 May; 319(1):87-106. PubMed ID: 12051939
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of the human LRH-1 DBD-DNA complex reveals Ftz-F1 domain positioning is required for receptor activity.
Solomon IH; Hager JM; Safi R; McDonnell DP; Redinbo MR; Ortlund EA
J Mol Biol; 2005 Dec; 354(5):1091-102. PubMed ID: 16289203
[TBL] [Abstract][Full Text] [Related]
8. Expression, purification, and initial structural characterization of rat orphan nuclear receptor NOR-1 LBD domain.
Razzera G; Vernal J; Portugal RV; Calgaro MR; Fernandez P; Zakin MM; Polikarpov I; Terenzi H
Protein Expr Purif; 2004 Oct; 37(2):443-9. PubMed ID: 15358368
[TBL] [Abstract][Full Text] [Related]
9. A dynamic mechanism of nuclear receptor activation and its perturbation in a human disease.
Kallenberger BC; Love JD; Chatterjee VK; Schwabe JW
Nat Struct Biol; 2003 Feb; 10(2):136-40. PubMed ID: 12536206
[TBL] [Abstract][Full Text] [Related]
10. Structural insight into PPARgamma activation through covalent modification with endogenous fatty acids.
Waku T; Shiraki T; Oyama T; Fujimoto Y; Maebara K; Kamiya N; Jingami H; Morikawa K
J Mol Biol; 2009 Jan; 385(1):188-99. PubMed ID: 18977231
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the growth arrest and DNA damage-inducible gene 45 (GADD45) by peroxisome proliferator-activated receptor gamma in vascular smooth muscle cells.
Bruemmer D; Yin F; Liu J; Berger JP; Sakai T; Blaschke F; Fleck E; Van Herle AJ; Forman BM; Law RE
Circ Res; 2003 Aug; 93(4):e38-47. PubMed ID: 12881480
[TBL] [Abstract][Full Text] [Related]
12. Hydrogen/deuterium-exchange (H/D-Ex) of PPARgamma LBD in the presence of various modulators.
Hamuro Y; Coales SJ; Morrow JA; Molnar KS; Tuske SJ; Southern MR; Griffin PR
Protein Sci; 2006 Aug; 15(8):1883-92. PubMed ID: 16823031
[TBL] [Abstract][Full Text] [Related]
13. Control of COX-2 gene expression through peroxisome proliferator-activated receptor gamma in human cervical cancer cells.
Han S; Inoue H; Flowers LC; Sidell N
Clin Cancer Res; 2003 Oct; 9(12):4627-35. PubMed ID: 14555539
[TBL] [Abstract][Full Text] [Related]
14. Stabilization of peroxisome proliferator-activated receptor alpha by the ligand.
Hirotani M; Tsukamoto T; Bourdeaux J; Sadano H; Osumi T
Biochem Biophys Res Commun; 2001 Oct; 288(1):106-10. PubMed ID: 11594759
[TBL] [Abstract][Full Text] [Related]
15. Molecular dynamics simulations of human LRH-1: the impact of ligand binding in a constitutively active nuclear receptor.
Burendahl S; Treuter E; Nilsson L
Biochemistry; 2008 May; 47(18):5205-15. PubMed ID: 18410128
[TBL] [Abstract][Full Text] [Related]
16. Microsecond-to-millisecond conformational dynamics demarcate the GluR2 glutamate receptor bound to agonists glutamate, quisqualate, and AMPA.
Valentine ER; Palmer AG
Biochemistry; 2005 Mar; 44(9):3410-7. PubMed ID: 15736951
[TBL] [Abstract][Full Text] [Related]
17. NMR solution structure of the inserted domain of human leukocyte function associated antigen-1.
Legge GB; Kriwacki RW; Chung J; Hommel U; Ramage P; Case DA; Dyson HJ; Wright PE
J Mol Biol; 2000 Feb; 295(5):1251-64. PubMed ID: 10653701
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms for ligand binding to GluR0 ion channels: crystal structures of the glutamate and serine complexes and a closed apo state.
Mayer ML; Olson R; Gouaux E
J Mol Biol; 2001 Aug; 311(4):815-36. PubMed ID: 11518533
[TBL] [Abstract][Full Text] [Related]
19. Co-regulator recruitment and the mechanism of retinoic acid receptor synergy.
Germain P; Iyer J; Zechel C; Gronemeyer H
Nature; 2002 Jan; 415(6868):187-92. PubMed ID: 11805839
[TBL] [Abstract][Full Text] [Related]
20. Molecular dynamics simulation of the ligand binding domain of farnesoid X receptor. Insights into helix-12 stability and coactivator peptide stabilization in response to agonist binding.
Costantino G; Entrena-Guadix A; Macchiarulo A; Gioiello A; Pellicciari R
J Med Chem; 2005 May; 48(9):3251-9. PubMed ID: 15857131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
